期刊文献+

Value of two-phase dynamic multidetector computed tomography in differential diagnosis of post-inflammatory strictures from esophageal cancer 被引量:3

Value of two-phase dynamic multidetector computed tomography in differential diagnosis of post-inflammatory strictures from esophageal cancer
在线阅读 下载PDF
导出
摘要 AIM: To characterize the computed tomography(CT) findings in patients with post-inflammatory esophageal strictures(corrosive and peptic) and reveal the optimal scanning phase protocols for distinguishing postinflammatory esophageal stricture and esophageal cancer.METHODS: Sixty-five patients with esophageal strictures of different etiology were included in this study: 24 patients with 27 histopathologically confirmed corrosive strictures, 10 patients with 12 peptic strictures and 31 patients with esophageal cancer were evaluated with a two-phase dynamic contrast-enhanced MDCT. Arterial and venous phases at 10 and 35 s after the attenuation of 200 HU were obtained at the descending aorta, with a delayed phase at 6-8 min after the start of injection of contrast media. For qualitative analysis, CT scans of benign strictures were reviewed for the presence/absence of the following features: "target sign", luminal mass, homogeneity of contrast medium uptake, concentric wall thickening, conically shapedsuprastenotic dilatation, smooth boundaries of stenosis and smooth mucous membrane at the transition to stenosis, which were compared with a control group of 31 patients who had esophageal cancer. The quantitative analysis included densitometric parameter acquisition using regions-of-interest measurement of the zone of stenosis and normal esophageal wall and the difference between those measurements(ΔCT) at all phases of bolus contrast enhancement. Esophageal wall thickening, length of esophageal wall thickening and size of the regional lymph nodes were also evaluated. RESULTS: The presence of a concentric esophageal wall, conically shaped suprastenotic dilatation, smooth upper and lower boundaries, "target sign" and smooth mucous membrane at the transition to stenosis were suggestive of a benign cause, with sensitivities of 92.31%, 87.17%, 94.87%, 76.92% and 82.05%, respectively, and specificities of 70.96%, 89.66%, 80.65%, 96.77% and 93.55%, respectively. The features that were most suggestive of a malignant cause were eccentric esophageal wall thickening, tuberous upper and lower boundaries of stenosis, absence of mucous membrane visualization, rupture of the mucous membrane at the upper boundary of stenosis, cup-shaped suprastenotic dilatation, luminal mass and enlarged regional lymph nodes with specificities of 92.31% 94.87%, 67.86%, 100%, 97.44%, 94.87% and 82.86%, respectively and sensitivities of 70.97%, 80.65%, 96.77%, 80.65%, 54.84%, 87.10% and 60%, respectively. The highest tumor attenuation occurred in the arterial phase(mean attenuation 74.13 ± 17.42 HU), and the mean attenuation difference between the tumor and the normal esophageal wall(mean ΔCT) in the arterial phase was 23.86 ± 19.31 HU. Here, 11.5 HU of ΔCT in the arterial phase was the cut-off value used to differentiate esophageal cancer from post-inflammatory stricture(P = 0.000). The highest attenuation of postinflammatory strictures occurred in the delayed phase(mean attenuation 71.66 ± 14.28 HU), and the mean ΔCT in delayed phase was 34.03 ± 15.94 HU. Here, 18.5 HU of ΔCT in delayed phase was the cut-off value used to differentiate post-inflammatory stricture from esophageal cancer(P < 0.0001).CONCLUSION: The described imaging findings reveal high diagnostic significance in the differentiation of benign strictures from esophageal cancer. AIM: To characterize the computed tomography(CT) findings in patients with post-inflammatory esophageal strictures(corrosive and peptic) and reveal the optimal scanning phase protocols for distinguishing postinflammatory esophageal stricture and esophageal cancer.METHODS: Sixty-five patients with esophageal strictures of different etiology were included in this study: 24 patients with 27 histopathologically confirmed corrosive strictures, 10 patients with 12 peptic strictures and 31 patients with esophageal cancer were evaluated with a two-phase dynamic contrast-enhanced MDCT. Arterial and venous phases at 10 and 35 s after the attenuation of 200 HU were obtained at the descending aorta, with a delayed phase at 6-8 min after the start of injection of contrast media. For qualitative analysis, CT scans of benign strictures were reviewed for the presence/absence of the following features: 'target sign', luminal mass, homogeneity of contrast medium uptake, concentric wall thickening, conically shapedsuprastenotic dilatation, smooth boundaries of stenosis and smooth mucous membrane at the transition to stenosis, which were compared with a control group of 31 patients who had esophageal cancer. The quantitative analysis included densitometric parameter acquisition using regions-of-interest measurement of the zone of stenosis and normal esophageal wall and the difference between those measurements(ΔCT) at all phases of bolus contrast enhancement. Esophageal wall thickening, length of esophageal wall thickening and size of the regional lymph nodes were also evaluated. RESULTS: The presence of a concentric esophageal wall, conically shaped suprastenotic dilatation, smooth upper and lower boundaries, 'target sign' and smooth mucous membrane at the transition to stenosis were suggestive of a benign cause, with sensitivities of 92.31%, 87.17%, 94.87%, 76.92% and 82.05%, respectively, and specificities of 70.96%, 89.66%, 80.65%, 96.77% and 93.55%, respectively. The features that were most suggestive of a malignant cause were eccentric esophageal wall thickening, tuberous upper and lower boundaries of stenosis, absence of mucous membrane visualization, rupture of the mucous membrane at the upper boundary of stenosis, cup-shaped suprastenotic dilatation, luminal mass and enlarged regional lymph nodes with specificities of 92.31% 94.87%, 67.86%, 100%, 97.44%, 94.87% and 82.86%, respectively and sensitivities of 70.97%, 80.65%, 96.77%, 80.65%, 54.84%, 87.10% and 60%, respectively. The highest tumor attenuation occurred in the arterial phase(mean attenuation 74.13 ± 17.42 HU), and the mean attenuation difference between the tumor and the normal esophageal wall(mean ΔCT) in the arterial phase was 23.86 ± 19.31 HU. Here, 11.5 HU of ΔCT in the arterial phase was the cut-off value used to differentiate esophageal cancer from post-inflammatory stricture(P = 0.000). The highest attenuation of postinflammatory strictures occurred in the delayed phase(mean attenuation 71.66 ± 14.28 HU), and the mean ΔCT in delayed phase was 34.03 ± 15.94 HU. Here, 18.5 HU of ΔCT in delayed phase was the cut-off value used to differentiate post-inflammatory stricture from esophageal cancer(P < 0.0001).CONCLUSION: The described imaging findings reveal high diagnostic significance in the differentiation of benign strictures from esophageal cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第29期8878-8887,共10页 世界胃肠病学杂志(英文版)
关键词 MULTIDETECTOR computed tomography Esophageal cancer Corrosive STRICTURE PEPTIC STRICTURE Multidetector computed tomography Esophageal cancer Corrosive stricture Peptic stricture
  • 相关文献

参考文献29

  • 1Desai RK, Tagliabue JR, Wegryn SA, Einstein DM. CT evaluationof wall thickening in the alimentary tract. Radiographics 1991;11: 771-783; discussion 784 [PMID: 1947313 DOI: 10.1148/radiographics.11.5.1947313].
  • 2Reinig JW, Stanley JH, Schabel SI. CT evaluation of thickenedesophageal walls. AJR Am J Roentgenol 1983; 140: 931-934 [PMID:6601436 DOI: 10.2214/ajr.140.5.931].
  • 3Ba-Ssalamah A, Zacherl J, Noebauer-Huhmann IM, Uffmann M,Matzek WK, Pinker K, Herold C, Schima W. Dedicated multidetectorCT of the esophagus: spectrum of diseases. AbdomImaging 2009; 34: 3-18 [PMID: 17653787 DOI: 10.1007/s00261-007-9290-5].
  • 4Jang KM, Lee KS, Lee SJ, Kim EA, Kim TS, Han D, Shim YM.The spectrum of benign esophageal lesions: imaging findings.Korean J Radiol 2002; 3: 199-210 [PMID: 12271166 DOI: 10.3348/kjr.2002.3.3.199].
  • 5Ella A, Barry H. Cardiopulmonary imaging. Philadelphia: LippincottWilliams and Wilkins, 2004: 189-194.
  • 6Carrascosa P, Capunay C, Martin Lopez E, Salis G, Mazzadi S,Carrascosa J. Esophageal stenosis: three-dimensional multidetectorCT and virtual endoscopy. Abdom Imaging 2009; 34: 19-25 [PMID:18709406 DOI: 10.1007/s00261-008-9435-1].
  • 7Allen DC. Histopathology reporting. London: Springer-Verlag,2013: 3-15 [DOI: 10.1007/978-1-4471-5263-7_1].
  • 8Takubo K. Pathology of the Esophagus 2nd Edition. Tokyo, Educa:Springer, 2007: 49-56, 84-94.
  • 9Dionigi G, Rovera F, Boni L, Bellani M, Bacuzzi A, Carrafiello G,Dionigi R. Cancer of the esophagus: the value of preoperative patientassessment. Expert Rev Anticancer Ther 2006; 6: 581-593 [PMID:16613545 DOI: 10.1586/14737140.6.4.581].
  • 10Berkovich GY, Levine MS, Miller WT. CT findings in patients withesophagitis. AJR Am J Roentgenol 2000; 175: 1431-1434 [PMID:11044057 DOI: 10.2214/ajr.175.5.1751431].

同被引文献11

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部